(Q42537404)

1 November 2017

Comparison of antiviral compounds against human herpesvirus 6 and 7. (English)

1 reference

1 November 2017

human herpesvirus 6

1 reference

Yoshida M

1

1 reference

1 November 2017

Yamada M

2

1 reference

1 November 2017

Tsukazaki T

3

1 reference

1 November 2017

Chatterjee S

4

1 reference

1 November 2017

Lakeman FD

5

1 reference

1 November 2017

Nii S

6

1 reference

1 November 2017

Whitley RJ

7

1 reference

1 November 2017

1 December 1998

1 reference

1 November 2017

1 reference

1 November 2017

40

1 reference

1 November 2017

1-2

1 reference

1 November 2017

73-84

1 reference

Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

In vitro sensitivity of human herpesvirus-6 to antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Reactivation of Herpesvirus Type 6 in Children Receiving Bone Marrow Transplants for Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Frequent isolation of human herpesvirus 7 from saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Biologic properties of human herpesvirus 7 strain SB.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Susceptibility of human herpesvirus 6 to antivirals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Mechanism of action of foscarnet against viral polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

1 reference

7 January 2021

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Isolation of human lymphotropic herpesviruses from Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Isolation of a new herpesvirus from human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

A new class of acyclic phosphonate nucleotide analogs: Phosphonate isosteres of acyclovir and ganciclovir monophosphates as antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Characteristics of human herpesvirus-6

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Human herpesvirus 6 is associated with focal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Determination and analysis of the complete nucleotide sequence of human herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Human herpesvirus 6 infection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

In vitro inhibition of human herpesvirus-6 by phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Transmission of human herpesvirus 7 through multigenerational families in the same household.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Human herpesvirus 7: another causal agent for roseola (exanthem subitum)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Human herpesvirus 7 infection associated with central nervous system manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Prolonged viremia and immune response to human herpesvirus 7 in an infant with liver dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Development of a dot blot neutralizing assay for HHV-6 and HHV-7 using specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Acyclovir: A Decade Later

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900049-7

7 January 2021

10.1016/S0166-3542(98)00049-7

Identifiers

DOI

1 reference

1 November 2017

1 reference